NVL and systemic sclerosis: Using two prototype immunoassays based on the identified autoantigen for serological testing in SARD patients, anti-NVL AAb were detected in 1.1% (4/378, 95% CI: 0.3–2.7%) of SSc patients but not in other disease groups or healthy controls.